Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Enable low abundant TH17 Cytokines; Powered by Singulex; High-Definition Erenna® Technology

Product Image
Product Description

Leveraging TH17 pathway biomarkers in chronic inflammatory diseases is highly challenging due to their low abundance. Recent research shows that detection and monitoring of TH17 cytokine concentrations can provide insights into disease progression and thus, cytokines have become attractive biomarkers and candidates for targeted therapies. These biomarkers are key members of the IL-17 signaling pathway, serving to induce and mediate pro-inflammatory responses in numerous immune mediated diseases, such as Rheumatoid Arthritis and asthma, among others.

Powered by Singulex; high-definition Erenna® technology’s powerful suite of TH17 pathway immunoassay kits, with LLoQ down to the sub picogram levels, offers researchers unique and novel insights, enabling quicker and more confident decision making. To Learn More:  Download TH17 Pathway Solutions!

Unless otherwise noted, Singulex products are for research use only and not intended for diagnostics use.

Watch High-Definition Erenna® Technology Video >>

Singulex1.gif

Singulex2.gif

Download TH17 Pathway Solutions!

Product Enable low abundant TH17 Cytokines; Powered by Singulex; High-Definition Erenna® Technology
Company Singulex
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Singulex
1701 Harbor Bay Parkway, Alameda, California, 94502, USA

Tel: +1.888.995.6955
Fax: +1.510.995.9090
Email: info@singulex.com



Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Antibody Drug Shows Promise in HIV Treatment
Researchers are a step closer to an alternative HIV treatment that has the potential for lasting effects and less frequent dosing.
Targeting Autoimmunity
Researchers have developed a strategy to treat a rare autoimmune disease which could lead to treatments of other autoimmune diseases.
Flu Vaccine May Reduce Death Risk of Type 2 Diabetes
New research suggests that a new flu vaccine may reduce probability of type 2 diabetes patients being hospitalised with stroke and heart failure.
Gut Bacteria Older than Human Species
Some bacteria have lived in the human gut since before we were human, suggesting evolution could have a larger role inhuman bacterial makeup.
Evidence of Mosquito Transmitting Zika
A direct link between the Yellow fever mosquito and Zika transmission has been found following investigation into selective mosquito control.
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Three-Drug Combinations Counter Antibiotic Resistance
Research shows that combinations of three different antibiotics can treat resistant bacteria, even if they are ineffective independently.
Mapping Zika’s Routes to Developing Fetus
UC researchers show how Zika virus travels from a pregnant woman to her fetus, and also identified a drug that could stop it.
Treating HIV with Cancer-Fighting Gene Shows Promise
A type of gene immunotherapy that has shown promising results against cancer could also be used against HIV.

Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!